Follow
Andrew Erickson
Title
Cited by
Cited by
Year
PTEN loss but not ERG expression in diagnostic biopsies is associated with increased risk of progression and adverse surgical findings in men with prostate cancer on active …
U Lokman, AM Erickson, H Vasarainen, AS Rannikko, T Mirtti
European urology focus 4 (6), 867-873, 2018
452018
Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy
K Lahdensuo, A Erickson, I Saarinen, H Seikkula, J Lundin, M Lundin, ...
Modern Pathology 29 (12), 1565-1574, 2016
432016
New prostate cancer grade grouping system predicts survival after radical prostatectomy
A Erickson, K Sandeman, K Lahdensuo, S Nordling, M Kallajoki, ...
Human pathology 75, 159-166, 2018
212018
Repeat multiparametric MRI in prostate cancer patients on active surveillance
JT Eineluoto, P Järvinen, A Kenttämies, TP Kilpeläinen, H Vasarainen, ...
PloS one 12 (12), e0189272, 2017
212017
Fibroblast as a critical stromal cell type determining prognosis in prostate cancer
S Blom, A Erickson, A Östman, A Rannikko, T Mirtti, O Kallioniemi, ...
The Prostate 79 (13), 1505-1513, 2019
202019
Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy
JK Björk, I Ahonen, T Mirtti, A Erickson, A Rannikko, A Bützow, S Nordling, ...
Oncotarget 9 (58), 31200, 2018
182018
Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005–2013: a population-based analysis
K Lahdensuo, A Rannikko, VJ Anttila, A Erickson, A Pätäri-Sampo, ...
Prostate cancer and prostatic diseases 19 (4), 417-422, 2016
152016
Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors
V Udhane, C Maranto, DT Hoang, L Gu, A Erickson, S Devi, PG Talati, ...
Molecular Cancer Therapeutics 19 (1), 231-246, 2020
122020
Positive STAT5 protein and locus amplification status predicts recurrence after radical prostatectomy to assist clinical precision management of prostate cancer
BR Haddad, A Erickson, V Udhane, PS LaViolette, JD Rone, MA Kallajoki, ...
Cancer Epidemiology and Prevention Biomarkers 28 (10), 1642-1651, 2019
102019
A systematic review of prostate cancer heterogeneity: understanding the clonal ancestry of multifocal disease
A Erickson, A Hayes, T Rajakumar, C Verill, RJ Bryant, FC Hamdy, ...
European urology oncology, 2021
62021
Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer
K Sopyllo, AM Erickson, T Mirtti
Cancers 13 (4), 628, 2021
42021
Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study
AM Erickson, S Luzzago, A Semjonow, H Vasarainen, TD Laajala, G Musi, ...
European Urology Oncology 1 (4), 268-275, 2018
42018
274 Prostate cancer active surveillance: Health-related quality of life in the Finnish arm of the prospective PRIAS-study. Three year update
U Lokman, H Vasarainen, K Lahdensuo, AM Erickson, K Taari, TK Mirtti, ...
European Urology Supplements 12 (1), e274-e275, 2013
42013
Transcript analysis of commercial prostate cancer risk stratification panels in hard‐to‐predict grade group 2–4 prostate cancers
TPK Lehto, C Stürenberg, A Malén, AM Erickson, H Koistinen, IG Mills, ...
The Prostate 81 (7), 368-376, 2021
32021
Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy
K Sandeman, JT Eineluoto, J Pohjonen, A Erickson, TP Kilpeläinen, ...
Plos one 15 (7), e0235779, 2020
32020
PP2A inhibitor PME-1 suppresses anoikis, and is associated with therapy relapse of PTEN-deficient prostate cancers
C Rupp, A Aakula, A Isomursu, A Erickson, O Kauko, P Shah, A Padzik, ...
bioRxiv, 581660, 2019
32019
Ductal adenocarcinoma of the prostate: A systematic review and meta‐analysis of incidence, presentation, prognosis, and management
N Ranasinha, A Omer, Y Philippou, E Harriss, L Davies, K Chow, ...
BJUI Compass, 0
3
PTEN and ERG expression in MRI‐ultrasound guided fusion biopsy correlated with radical prostatectomy findings in men with prostate cancer
AM Erickson, U Lokman, K Lahdensuo, S Tornberg, H Visapaa, ...
The Prostate 80 (13), 1118-1127, 2020
22020
The role of enzalutamide-induced hyperactive Jak2-Stat5 feed-forward signaling loop on enzalutamide-resistant prostate cancer growth and as a therapeutic target for second-line …
V Udhane, C Maranto, D Hoang, A Erickson, S Devi, K Jacobsohn, ...
Journal of Clinical Oncology 37 (7_suppl), 221-221, 2019
22019
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent subpopulations of cells associated with relapse of prostate cancer
S Taavitsainen, N Engedal, S Cao, F Handle, A Erickson, S Prekovic, ...
12021
The system can't perform the operation now. Try again later.
Articles 1–20